PEI - A potent, but not harmless, mucosal immuno-stimulator of mixed T-helper cell response and FasL-mediated cell death in mice

Gene Therapy

Volumn 10, Issue 18, 2003, Pages 1575-1583

  Regnstrom K ^a   Ragnarsson, E G E ^a   Koping Hoggard M ^a   Torstensson, E ^a   Nyblom, H ^a   Artursson, P ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

cDNA array; DNA vaccine; Gene expression; Nonviral gene delivery; Polyethyleneimine; Systemic immune response

Indexed keywords

ALUMINUM PHOSPHATE; CD4 ANTIGEN; CD8 ANTIGEN; DIPHTHERIA VACCINE; DNA VACCINE; FAS LIGAND; POLYETHYLENEIMINE; TETANUS TOXOID;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DEATH; CELLULAR IMMUNITY; CONTROLLED STUDY; GENE ACTIVATION; GENE DELIVERY SYSTEM; GENE EXPRESSION PROFILING; HELPER CELL; IMMUNIZATION; IMMUNOSTIMULATION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ANIMALS; APOPTOSIS; FAS LIGAND PROTEIN; GENE EXPRESSION; GENE THERAPY; IMMUNIZATION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; POLYETHYLENEIMINE; T-LYMPHOCYTES, HELPER-INDUCER; VACCINES, DNA;

ANIMALIA;

EID: 0042377443     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302054     Document Type: Article

References (45)

1. Brown MD, Schätzlein AG, Uchegbu IF. Gene delivery with synthetic (non viral) carriers. Int J Pharm 2001; 229: 1-21.
2. Ulmer JB et al. Induction of immunity by DNA vaccination: application to influenza and tuberculosis. Behring Inst Mitt 1997; 98: 79-86.
3. Raz E et al. Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci USA 1994; 91: 9519-9523.
4. Klavinskis LS, Barnfield C, Gao L, Parker S. Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts. J Immunol 1999;162: 254-262.
5. Gregoriadis G, Saffie R, De Souza JB. Liposome-mediated DNA vaccination. FEBS Lett 1997; 402: 107-110.
6. Singh M, Briones M, Ott G, O'Hagan D. Cationic microparticles a potent delivery system for DNA vaccines. Proc Natl Acad Sci USA 2000; 97: 811-816.
7. Roy K, Mao HQ, Huang SK, Leong KW. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 1999; 5: 387-391.
8. Boussif O et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethyleneimine. Proc Natl Acad Sci USA 1995; 92: 7297-7301.
9. Godbey WT, Wu KK, Mikos AG. Tracking the intracellular path of poly (ethyleneimine)/DNA complexes for gene therapy. Proc Natl Acad Sci USA 1999; 96: 5177-5181.
10. Pollard H et al. Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J Biol Chem 1998; 273: 7505-7511.
11. Kichler A, Leborgne C, Coeytaux E, Danos O. Polyethyleneimine-mediated gene delivery: a mechanistic study. J Gene Med 2001; 3: 135-144.
12. Densmore CL et al. Aerosol delivery of robust polyethyleneimine-DNA complexes for gene therapy and genetic immunization. Mol Ther 2000; 1: 180-188.
13. Plank C, Mechtler K, Szoka Jr FC, Wagner E. Activation of the Complement System by Synthetic DNA Complexes: A Potential barrier of Intravenous Gene Delivery. Hum Gene Ther 7: 1437-1446.
14. Regnström K et al. Tetanus antigen modulates the gene expression profile of aluminum phosphate in spleen lymphocytes in vivo. Pharmacogenomics J 2002; 2: 57-64.
15. Teague TK et al. Activation changes the spectrum but not the diversity of genes expressed by T cells. Proc Natl Acad Sci USA 1999; 96: 12691-12696.
16. Regnström K, Ragnarsson EGE, Artursson P. Expression profiles of clinical relevant diphtheria and tetanus vaccines. Vaccine 2003 (in press).
17. Ferrari S et al. Polyethyleneimine shows properties of interest for cystic fibrosis gene therapy. Biochim Biophys Acta 1999; 1447: 219-225.
18. Tamayo P et al. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci USA 1999; 96: 2907-2912.
19. +memory T cells. Proc Natl Acad Sci USA 2002; 99: 6192-6197.
20. Jensen TK, Laegreid A, Komorowski J, Hovig E. A literature network of human genes for high-throughput analysis of gene expression. Nat Genet 2001; 28: 21-28.
21. Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D. GeneCards: encyclopaedia for genes, proteins and diseases. Trends Genet 1997; 13: 163.
22. Bustin SA, Jenkins PJ. The growth hormone-insulin-like growth factor-I axis and colorectal cancer. Trends Mol Med 2001; 7: 447-454.
23. Matzinger P. An innate sense of danger. Semin Immunol 1998; 10: 399-415.
24. Conley ME, Delacroix DL. Intravascular and mucosal immunoglobulin A: two separate but related systems of immune defense. Ann Intern Med 1987; 106: 892-899.
25. Mäkelä PH. Vaccines, coming of age after 200 years. FEMS Microbiol Rev 2000; 24: 9-20.
26. Krishnan S, Haensler J, Meulien P. Paving the way towards DNA vaccines. Nat Med 1995; 1: 521-522.
27. Roman M et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvant. Nat Med 1997; 3: 849-854.
28. Quiding-Järbrink M et al. Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. J Clin Invest 1997; 99: 1281-1286.
29. Surh CD, Sprent J. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 1994; 372: 100-103.
30. Hildeman DA et al. Molecular mechanisms of activated T-cell death in vivo. Curr Opin Immunol 2002; 14: 354-359.
31. Kiefer MC et al. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 1995; 374: 736-739.
32. Boise LH et al. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74: 597-608.
33. Wang K et al. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-619.
34. Crispe IN. Death and destruction of activated T lymphocytes. Immunol Res 1999; 19: 143-157.
35. Alderson MR et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 1995; 181: 71-77.
36. Vito P, Lacana E, D'Adamio L. Interfering with apoptosis: Ca (2+) binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 1996; 271: 521-525.
37. Mitchell TC et al. Immunological adjuvants promote activated T cell survival via induction of Bcl-3. Nat Immunol 2001; 13: 114-119.
38. Hamad AR, Schneck JP. Antigen-induced T-cell death is regulated by CD4 expression. Int Rev Immunol 2001; 20: 535-546.
39. Rebello A et al. Bcl-3 expression promotes cell survival following interleukin 4 deprivation and is controlled by AP1 and AP1 like transcription factors. Mol Cell Biol 2000; 20: 3407-3416.
40. Tavazoie S, Church GM. Quantitative whole-genome analysis of DNA-protein interactions by in vivo methylase protection in E. Coli. Nat Biotechnol 1998; 16: 566-571.
41. Helander IM, Latva-Kala K, Lounatmaa K. Permeabilizing action of polyethyleneimin on Salmonella typhimurium involves disruption of the outer membrane with lipopolysaccharide. Microbiology 1998; 144: 385-390.
42. Helander IM, Alakomi HL, Latva-Kala K, Koski P. Polyethyleneimine is an effective permeabilizer of Gram-negative bacteria. Microbiology 1997; 143: 3193-3199.
43. Lashuel HA et al. Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 2002; 418: 291.
44. Godbey WT, Wu KK, Hirasaki GJ, Mikos AG. Improved packing of poly(ethylene-imine)/DNA complexes increases transfection efficiency. Gene Therapy 1999; 6: 1380-1388.
45. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863-14868.